⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propene SCHEMBL30536991 | 0.93 | — | — | |
| Propene SCHEMBL30536989 | 0.93 | — | — | |
| Propene SCHEMBL4948068 | 0.93 | TSHR (0.33) | — | |
| Propene SCHEMBL8431129 | 0.93 | TSHR (0.33) | — | |
| Propene SCHEMBL193 | 0.93 | — | — | |
| Propene SCHEMBL8039600 | 0.93 | TSHR (0.33) | — | |
| Propene SCHEMBL8190454 | 0.93 | TSHR (0.33) | — | |
| Propene SCHEMBL342422 | 0.93 | — | — | |
| Propene SCHEMBL8064619 | 0.93 | — | — | |
| Propene SCHEMBL30536997 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2813222-B1 | FORMYLATED XANTHOCILLIN ANALOGUES AS NEUROPROTECTANTS | NEURON BIOPHARMA SA (ES) | 2016-07-06 | — | — | EP | claimed |
| US-20150011621-A1 | FORMYLATED XANTHOCILLIN ANALOGUES AS NEUROPROTECTIVE AGENTS | NEURON BIOPHARMA, S.A. (ES) | 2015-01-08 | — | — | US | claimed |
| EP-2813222-A2 | FORMYLATED XANTHOCILLIN ANALOGUES AS NEUROPROTECTANTS | Neuron Biopharma S.A. (ES) | 2014-12-17 | — | — | EP | claimed |
| EP-0879817-A1 | Conversion of pyridinoline to deoxypyridinoline | Bayer Corporation (US) | 1998-11-25 | — | — | EP | claimed |
| US-5834610-A | Conversion of pyridinoline to deoxypyridinoline | BAYER CORPORATION | 1998-11-10 | — | — | US | claimed |
| EP-0653437-B1 | Process for preparing AZT and derivatives thereof | BRISTOL MYERS SQUIBB CO (US) | 1997-08-13 | — | — | EP | claimed |
| EP-0653437-A1 | Process for preparing AZT and derivatives thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-05-17 | — | — | EP | claimed |
| EP-0216614-A2 | Synthesis of steroids and intermediates therof | THE UNIVERSITY OF SHEFFIELD (GB) | 1987-04-01 | — | — | EP | claimed |
| JP-7188279-A | — | — | None | — | — | JP | disclosed |
| US-9453004-B2 | Formylated xanthocillin analogues as neuroprotective agents | NEURON BIOPHARMA, S.A. (ES) | 2016-09-27 | — | — | US | disclosed |
| US-9388154-B2 | Process for preparing synthetic prostacyclins | Lund Biotechnology PBC (US) | 2016-07-12 | — | — | US | disclosed |
| EP-2813222-B1 | FORMYLATED XANTHOCILLIN ANALOGUES AS NEUROPROTECTANTS | NEURON BIOPHARMA SA (ES) | 2016-07-06 | — | — | EP | disclosed |
| US-20150025255-A1 | PROCESS FOR PREPARING SYNTHETIC PROSTACYCLINS | LUNG BIOTECHNOLOGY INC. (US) | 2015-01-22 | — | — | US | disclosed |
| US-20150011621-A1 | FORMYLATED XANTHOCILLIN ANALOGUES AS NEUROPROTECTIVE AGENTS | NEURON BIOPHARMA, S.A. (ES) | 2015-01-08 | — | — | US | disclosed |
| EP-0013617-B1 | PENICILLIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING CERTAIN OF THESE COMPOUNDS | BEECHAM GROUP PLC (GB) | 1984-07-04 | — | — | EP | disclosed |
| US-4370326-A | THIAZOLE-SUBSTITUTED | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| US-4347182-A | Preparation of penicillanic acid derivatives | BEECHAM GROUP LIMITED (GB) | 1982-08-31 | — | — | US | disclosed |
| EP-0001125-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-11-11 | — | — | EP | disclosed |
| EP-0013617-A1 | Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds | BEECHAM GROUP PLC (GB) | 1980-07-23 | — | — | EP | disclosed |
| EP-0001125-A2 | Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-03-21 | — | — | EP | disclosed |